An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model (Q40504189)

21 September 2017

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model (English)

1 reference

21 September 2017

0 references

1 reference

0 references

20

1 reference

21 September 2017

18

Kenneth H Eckels

1 reference

21 September 2017

J Robert Putnak

1

1 reference

21 September 2017

Beth-Ann Coller

2

1 reference

21 September 2017

Gerald Voss

3

1 reference

21 September 2017

David W Vaughn

4

1 reference

21 September 2017

David Clements

5

1 reference

21 September 2017

Iain Peters

6

1 reference

21 September 2017

Gary Bignami

7

1 reference

21 September 2017

Hou-Shu Houng

8

1 reference

21 September 2017

Robert C-M Chen

9

1 reference

21 September 2017

David A Barvir

10

1 reference

21 September 2017

Jitvimol Seriwatana

11

1 reference

21 September 2017

Sylvie Cayphas

12

1 reference

21 September 2017

Nathalie Garçon

13

1 reference

21 September 2017

Dirk Gheysen

14

1 reference

21 September 2017

Niranjan Kanesa-Thasan

15

1 reference

21 September 2017

Mike McDonell

16

1 reference

21 September 2017

Tom Humphreys

17

1 reference

21 September 2017

Jean-Paul Prieels

19

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

35

1 reference

21 September 2017

4442-4452

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

21 September 2017

1 reference

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Live attenuated tetravalent dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Regulated expression allows high level production and secretion of HIV-1 gp120 envelope glycoprotein in Drosophila Schneider cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Infection of an Aedes aegypti cell line with infectious arbovirus-antibody complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

A ligand-binding pocket in the dengue virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Structure of the dengue virus envelope protein after membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.03.042

1 reference

21 September 2017

1 reference